Trial NCT01347866

View at ClinicalTrials.gov 
Org. Study IDs: B1271002
Secondary IDs: 2011-001671-39

Last trial update was posted on 2018-10-29

MeSH Interventions

Gedatolisib Irinotecan

MeSH Conditions

Neoplasms

Other Conditions

Advanced Cancer

Stopping Reasons

Refer to Detailed Description for documentaion of Termination Statement.

Limitations And Caveats

This study was terminated prematurely for strategic reasons based on an internal portfolio prioritization.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID